Epidemiological and Clinical Research Information Network
3 clinical trials · Sponsor
◉ Watch Epidemiological and Clinical Research Information Network
| Record | Firm | Date |
|---|---|---|
| A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC (NCT01996306) | Epidemiological and Clinical Research Information Network | 2013-12-02 |
| XParTS II: Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric Cancer (NCT01406249) | Epidemiological and Clinical Research Information Network | 2011-08-01 |
| XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer (NCT01412294) | Epidemiological and Clinical Research Information Network | 2011-07-01 |
Track Epidemiological and Clinical Research Information Network automatically
Every clearance here is in the API, with alerts when new ones post.